Intra-Cellular Therapies to Participate at Upcoming Investor Conferences
November 23 2016 - 8:00AM
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical
company focused on the development of therapeutics for central
nervous system ("CNS") disorders, today announced it will
participate at the following investor conferences in November 2016:
- 28th Annual Piper Jaffray Healthcare Conference taking place in
New York City from November 29-30, 2016. Sharon Mates, Ph.D.,
Chief Executive Officer and Chairman, will participate in a
Fireside Chat, on November 29, 2016 at 4:00 p.m. Eastern
Time.
- Leerink Partners' POLARxPRESS Bus Tour taking place
on November 30, 2016 in New York City. Sharon
Mates, Ph.D., will present at 1:30 p.m. Eastern Time.
The live webcast from the Piper Jaffray Healthcare Conference
can be accessed under "Events & Presentations" in the Investor
Relations section of the Company's website at
www.intracellulartherapies.com. Please log in approximately 5-10
minutes prior to the event to register and to download and install
any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is developing novel drugs for the
treatment of neuropsychiatric and neurodegenerative diseases and
diseases of the elderly, including Parkinson's and Alzheimer's
disease. The Company is developing its lead drug candidate,
ITI-007, for the treatment of schizophrenia, bipolar disorder,
behavioral disturbances in patients with dementia, including
Alzheimer's disease, depression and other neuropsychiatric and
neurological disorders. ITI-007, a first-in-class molecule, is in
Phase 3 clinical development for the treatment of schizophrenia,
bipolar depression and agitation associated with dementia,
including Alzheimer's disease. The Company is also utilizing its
phosphodiesterase platform and other proprietary chemistry
platforms to develop drugs for the treatment of CNS and other
disorders.
Contact:
Juan Sanchez, M.D.
Vice President
Corporate Communications and Investor Relations of Intra-Cellular Therapies, Inc.
Phone: 212-923-3344
Burns McClellan, Inc.
Lisa Burns
Justin Jackson (Media)
jjackson@burnsmc.com
212-213-0006
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Apr 2024 to May 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From May 2023 to May 2024